global biotech stocks

Latest news and analysis on global biotech stocks

Equities

When the market’s hot, go where it’s not: Biotech’s position of opportunity for FY26

Biotech stumbled in FY25, but we didn’t. HB Biotechnology kept its footing and delivered 23% outperformance in a tough market.
OPT
+3
Charlie Williams
HB Biotechnology
Equities

The small and mid-cap biotechs poised for a big breakout

...according to HB Biotechnology’s Charlie Williams.
OPT
+5
Sara Allen
Livewire Markets
2